TABLE 2.
Phytochemicals and their effects on gastric cancer via autophagy pathway.
Compounds | Experimental model/cells | Dose/duration | Autophagy mechanism | References |
---|---|---|---|---|
N-butylidenephthalide | AGS | 25, 50, 75 μg/mL; 24 h | ↑REDD1 | Liao et al. (2018) |
↓mTOR | ||||
Perillaldehyde | Xenograft model of gastric cancer | 100 mg/kg per day | Beclin-1, LC-3-II, cathepsin, p53-mediated autophagy | Zhang et al. (2018b) |
Terpenoid | AGS, MKN-45, KATO III | 10, 20, 30 μM; 24 h | ↑p-JNK, p-p38, p-AMPK, Bax, cyt c, caspase-3, c-PARP1, LC-3-II | Chun et al. (2014) |
↓p-ERK, p-AKT, p-mTOR, NF-κB, COX-2, cyclin D1, VEGF, Bcl-2, Bid | ||||
Kangfuxin | SGC-7901 | 0.1, 1 μg/mL; 48 h | ↑GRP78, CHOP, caspase-12, LC-3-II/LC-3-I, Bax | Chen et al. (2017) |
↓Bcl-2 | ||||
Rottlerin | SGC-7901, MGC-803 | 2 ,4, 8 μM; 24 h | ↑LC-3-II | Song et al. (2018) |
↓mTOR, Skp2 | ||||
Allicin | Human gastric cancer cell MGC-803, BGC-823, and SGC-7901 | 1 μg/mL | Increase expression of p38 and autophagy | Zhang et al. (2015) |
Evodiamine | SGC-7901 | 10 µM | Activates beclin-2 and autophagy | Rasul et al. (2012) |
Pectolinarigenin | AGS and MKN-28 | 50 and 100 μM | PI3K/AKT/mTOR signaling | Lee et al. (2018) |
3,3′-Diindolylmethane | BGC-823 and SGC-7901 | 60 μM | miR-30e-ATG-5 modulating autophagy | Ye et al. (2016) |
Latcripin 1 | SGC-7901 and BGC-823 | 30, 60, and 90 μM | ATG-7, ATG-5, ATG-12, ATG-14, and beclin-1 induction autophagy | Batool et al. (2018) |
Kaempferol | Human GC cell lines (AGS, SNU-216, NCI-N87, SNU-638, and MKN-74) | 50 μM | Activation of the IRE1-JNK-CHOP–mediated autophagy | Kim et al. (2018b) |